NAMSA completes acquisition of WuXi AppTec's U.S. Medical Device Testing Operations to strengthen its position in MedTech testing and clinical research
NAMSA completes acquisition of WuXi AppTec's U.S. Medical Device Testing Operations to strengthen its position in MedTech testing and clinical research
01/17/25, 3:41 PM
Location
Industry
pharmaceutical
biotechnology
manufacturing
NAMSA, a world-leading MedTech testing, clinical, and regulatory consulting firm, has announced the acquisition of the U.S. medical device testing operations of WuXi AppTec. This acquisition solidifies NAMSA's position as the leader in MedTech testing and clinical research, enabling the enhancement of capabilities and accelerating MedTech innovation for life-saving medical technology worldwide.
Company Info
Company info
NAMSA is a world-leading MedTech testing, clinical, and regulatory consulting firm dedicated to accelerating medical device product development. With a deep pool of testing, clinical, and regulatory experts, NAMSA helps medical device sponsors improve healthcare and is committed to enhancing stakeholder value through strategic outsourcing and comprehensive in-house services.